⚠ Evidence note: Exercise has the strongest human evidence base in this vault, but protocol-level specifics are far less settled than the headline benefit.
Resistance Training and Sarcopenia
Current understanding
Muscle as the retirement account: strength training against age-related loss.
Evidence log
- 2026-11-15 — Circulating C-Terminal Agrin Fragment is Associated with Impaired Physical Performance in Aging and Chronic Disease: A Systematic Review and Meta-Analysis.: [human-observational] Systematic review and meta-analysis of 21 studies involving over 3,000 individuals linked higher circulating CAF22 to poorer gait speed and SPPB performance, adding a candidate neuromuscular-junction-related biomarker to the sarcopenia assessment record without establishing that CAF22 causes impairment or that resistance training changes CAF22. [human-observational] (novelty: 3)
- 2026-11-09 — Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes: [expert-opinion] A 24-week clinical trial description (no results supplied) tests supervised resistance/interval training plus daily whey protein in adults with type 2 diabetes initiating semaglutide or tirzepatide, with thigh muscle volume, strength, and physical function as outcomes, without yet establishing muscle preservation or an effective training/protein dose. [expert-opinion] (novelty: 3)
- 2026-11-09 — Effectiveness of a Physical Exercise Prescription Program in Primary Care for Adults Aged 65 and Older: PREFIS-AP: [expert-opinion] PREFIS-AP trial description (no results supplied) tests an individualized primary-care exercise prescription including resistance, aerobic, balance, respiratory, and flexibility components versus standard walking advice in adults aged ≥65, with muscle function among the outcomes but no demonstrated benefit or isolated resistance-training effect. [expert-opinion] (novelty: 3)
- 2026-07-17 — Longitudinal associations between movement and sarcopenia, gait speed, and grip strength differ by frailty level in the Canadian Longitudinal Study on Aging.: [human-observational] Longitudinal Canadian Longitudinal Study on Aging analysis of over 10,000 adults associated light-to-moderate activity with lower sarcopenia risk in frail participants and strenuous activity with lower risk in robust participants, without isolating resistance training, establishing causal intensity thresholds, or excluding residual confounding and reverse causation. [human-observational] (novelty: 3)
- 2026-09-02 — A 12-week multimodal exercise program combining Baduanjin and resistance-band training improves muscle health in older adults with sarcopenia: A randomized controlled trial.: [human-rct] A 12-week four-arm RCT in older adults with sarcopenia reported significant improvements in appendicular muscle mass, gait speed, and physical-performance battery scores with combined Baduanjin and resistance-band training, while the supplied summary lacks sample size, effect estimates, and interaction analyses needed to establish synergy beyond additive benefits. [human-rct] (novelty: 3)
- 2026-10-01 — Nonpharmacological interventions for frailty and sarcopenia in older adults with gastrointestinal cancers: A Bayesian network meta-analysis.: [human-rct] Bayesian network meta-analysis of 21 RCTs in older adults with gastrointestinal cancers found mostly null or minimal, low- to very-low-certainty improvements in frailty, sarcopenia, and physical performance with nonpharmacological interventions including prehabilitation exercise and enhanced nutrition, without isolating resistance training’s contribution or establishing its ineffectiveness in other older populations. [human-rct] (novelty: 3)
- 2026-10-07 — Lysine degradation-related metabolic remodeling in sarcopenia: Mendelian randomization prioritization and multi-omics-based characterization.: [human-observational] Metabolome-wide Mendelian randomization integrated with human muscle and serum multi-omics prioritized lysine degradation and impaired trimethyllysine-derived carnitine biosynthesis as candidate contributors to reduced appendicular lean mass, addressing reverse-causation concerns through genetic instruments but retaining instrument-validity and pleiotropy caveats and providing no resistance-training or supplementation efficacy evidence. [human-observational] (novelty: 3)
- 2026-11-01 — Women With Bipolar Disorder are at Increased Risk of Sarcopenia.: [human-observational] Clinical observational comparison found women with bipolar disorder had more than twice the odds of sarcopenia versus age-matched controls after adjustment for measured physical activity, diet, and lifestyle factors, without establishing causation, excluding residual confounding or reverse causation, or testing resistance training. [human-observational] (novelty: 3)
- 2026-10-24 — Individual variability and predictors of responsiveness in physical outcomes following multicomponent physical training in older adults.: [human-observational] Response analysis of a 12-month multicomponent exercise intervention in older adults classified 46% as high multi-outcome responders and associated that classification with younger age, lower BMI, multimorbidity, and higher resistance-training adherence, without establishing causal predictors, isolating resistance training’s contribution, or confirming randomization in the supplied summary. [human-observational] (novelty: 3)
- 2026-10-31 — The effects of regular exercise and psychoeducation on quality of life, depression, and physical function in older adults with sarcopenia: A single-blind randomized controlled trial.: [human-rct] Eight-week single-blind RCT in institutionalized older adults with sarcopenia reported significantly greater reductions in depressive symptoms and improvements in quality of life with psychoeducation plus exercise versus exercise alone, without isolating resistance training’s contribution or establishing durable benefits. [human-rct] (novelty: 3)
- 2026-11-01 — Discordance Between Height- and BMI-Adjusted AWGS 2025 Definitions of Confirmed Sarcopenia After Stroke.: [human-observational] Observational comparison in post-stroke patients found more than 20% discordance in AWGS 2025 confirmed-sarcopenia classifications between height- and BMI-indexed muscle mass, documenting definition-dependent case identification without testing resistance training or establishing which definition better predicts functional outcomes. [human-observational] (novelty: 3)
- 2026-11-01 — Exercise and Nutritional Interventions for Muscle Strength, Physical Performance, and Body Composition Among Older Adults With Sarcopenia or Pre-Sarcopenia: A Network Meta-Analysis.: [human-rct] Network meta-analysis of 57 RCTs involving over 6,000 older adults with sarcopenia or pre-sarcopenia reported the greatest strength and appendicular muscle-mass gains with combined exercise and nutrition, without isolating resistance training’s contribution or establishing an optimal exercise or nutritional protocol. [human-rct] (novelty: 3)
- 2026-05-28 — Effect of exercise interventions on hand grip and TUG in older adults: A network meta-analysis of randomized controlled trials.: [human-rct] Network meta-analysis of 47 RCTs in older adults reported the greatest handgrip-strength and Timed Up and Go (TUG) improvements with multicomponent exercise plus nutritional support compared with single-modality exercise or control, without isolating the resistance-training or nutritional contribution or establishing prevention of clinical sarcopenia or an optimal protocol. [human-rct] (novelty: 3)
- 2026-08-08 — Effects of exercise and nutritional interventions on muscle-specific strength in older adults: A systematic review and meta-analysis.: [human-rct] Systematic review and meta-analysis of 41 RCTs in older adults found resistance training significantly improved muscle-specific strength (strength normalized to muscle mass), while nutritional supplementation, aerobic exercise, and concurrent training showed no statistically significant improvements on this endpoint, without establishing their ineffectiveness for other outcomes, resistance training’s superiority in direct comparisons, or an optimal training dose. [human-rct] (novelty: 3)
- 2026-08-27 — Effects of eccentric overload training on lower-limb muscle strength, gait performance, balance, and explosive power in older adults: A systematic review and meta-analysis.: [human-rct] Systematic review and meta-analysis of 15 RCTs in older adults reported improved lower-limb strength and explosive power with eccentric overload training, highlighting flywheel-based programs and durations of at least eight weeks without establishing device superiority, an optimal duration, or prevention of clinical sarcopenia. [human-rct] (novelty: 3)
- 2026-09-30 — Cannabigerol Enhances Muscle Strength and Performance in Dexamethasone-Treated Mice.: [animal-model] Mouse study of dexamethasone-induced muscle atrophy reported improved muscle power, peak grip strength, and lactate clearance with cannabigerol combined with resistance exercise, adding a preclinical adjunct signal without establishing synergy beyond additive effects, efficacy in age-related sarcopenia, or human benefits and dosing. [animal-model] (novelty: 3)
- 2026-10-19 — Resistance Training Improves Respiratory Muscle Strength and Immune Response in Older Adults: A Randomized Clinical Trial.: [human-rct] A 12-week randomized clinical trial of supervised resistance training in older adults reported improved respiratory muscle strength and physical performance, changes in systemic inflammatory markers, and increased circulating Klotho, without establishing Klotho-mediated benefits, durable immune protection, longevity effects, or optimal training dose. [human-rct] (novelty: 3)
- 2026-10-28 — Acute and Chronic Cardiovascular and Neuromuscular Effects of Blood Flow Restriction Resistance Training in Older Adults: A Systematic Review and Meta-Analysis.: [human-rct] Meta-analysis of 27 RCTs in older adults found low-load BFR resistance training increased lower-body strength and muscle cross-sectional area versus no exercise, adding randomized evidence for muscle-related outcomes without establishing superiority to conventional resistance training or prevention of clinical sarcopenia. [human-rct] (novelty: 3)
- 2026-11-03 — Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan.: [mechanism-plausible] Review (no new primary data) synthesizes proposed roles of SMOX-mediated spermidine generation in muscle maintenance through reduced senescence markers and restored satellite-cell autophagy, extending the mechanistic rationale for sarcopenia research without establishing human treatment efficacy, supplementation benefits, or resistance-training protocol specifics. [mechanism-plausible] (novelty: 3)
- 2026-09-28 — Loss ofdisrupts lipid signaling and causes slow muscle fiber degeneration.: [animal-model] Model-organism loss-of-function study identified Srebp1 as necessary for lipid mediator signaling, cardiolipin homeostasis, and slow oxidative muscle fiber survival, extending the page’s mitochondrial-lipid mechanism record without testing resistance training or establishing a human treatment effect. [animal-model] (novelty: 3)
- 2026-10-26 — Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine.: [expert-opinion] Review of skeletal muscle during SGLT2 inhibitor and incretin therapy (no new primary data) emphasizes functional monitoring and lifestyle countermeasures in vulnerable older adults, without establishing the preventive efficacy or optimal dose of resistance training during these treatments. [expert-opinion] (novelty: 3)
- 2026-10-29 — Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient-Centered Prescribing.: Geriatrics 5Ms framework review (no new primary data) positions resistance training and adequate protein as essential co-interventions during incretin-based obesity treatment in older adults, extending existing expert guidance without establishing their preventive efficacy or optimal dosing in this population. [expert-opinion] [expert-opinion] (novelty: 3)
- 2026-10-04 — Single-Nucleus Atlas of Spinal Sarcopenia Patients Reveals Disruption of Quiescent and Regenerative Satellite Cell Niches in Fatty-Infiltrated Muscle.: Single-nucleus atlas of spinal sarcopenia patients showed intramuscular fat fraction tracked with lower paraspinal mass and trunk strength and traced the signal to ANGPTL4–SDC2 suppression of satellite-cell myogenesis and expansion of a lipogenic GPC3+ FAP subpopulation — adds a human-tissue cellular-niche mechanism (satellite cell + FAP disruption) upstream of the strength loss that RT targets, without displacing resistance training as the human-evidenced lever. [human-observational] (novelty: 4)
- 2026-06-04 — Assessing Fall Risk in Older Adults: The Role of Reaction Time and Inhibitory Control Testing With ReacStick.: Cross-sectional ReacStick fall-risk study in community-dwelling older adults identified greater knee extensor strength as protective against recurrent faller status alongside reaction-time deficits as the stronger discriminator — associational reinforcement of the lower-limb strength–falls link, no intervention arm. [human-observational] (novelty: 3)
- 2026-07-21 — Comparative effects of 12-week resistance training on unstable and stable surfaces on muscle stiffness, muscle co-activation, and balance in older patients with knee osteoarthritis.: 12-week RCT in older adults with knee osteoarthritis compared resistance training on unstable vs stable surfaces and found the unstable-surface arm produced greater gains in balance and lowered muscle stiffness and quadriceps–hamstring co-activation, while both arms reduced pain — a modality-tweak signal within RT, small single-trial. [human-rct] (novelty: 3)
- 2026-08-14 — Exercise modalities for overall and domain-specific balance performance in older adults: A systematic review and Bayesian network meta-analysis.: Bayesian network meta-analysis of 423 RCTs on balance outcomes in adults ≥60 included resistance training among 19 modalities and found it improved overall balance but ranked below perturbation, sensory, dance, and agility work — a reminder that RT’s muscle/strength-anchored benefit does not automatically make it the top modality for balance-domain endpoints. [human-rct] (novelty: 3)
- 2026-08-31 — Effects of strength and balance training on the structure of the aging brain.: 3-month RCT in adults 64–82 using multimodal neuroimaging found strength training remodeled white-matter microstructure in key transmission pathways and mitigated aging-related corpus callosum demyelination vs passive controls — extends the RT case into a structural brain-plasticity readout, small-sample trial with imaging (not functional) endpoints. [human-rct] (novelty: 3)
- 2026-10-01 — Possible osteosarcopenia is associated with loss in intrinsic capacity and early cognitive deficits: a longitudinal study of older adults in Singapore.: Singapore longitudinal cohort tied possible osteosarcopenia (concurrent low grip/function + possible osteoporosis) to intrinsic-capacity loss and early cognitive deficits at 6 months, reinforcing the rationale for combined bone-and-muscle-targeted resistance training in older adults — observational, no intervention arm. [human-observational] (novelty: 3)
- 2026-08-26 — Clinical Trial: Intensive Supervised Nutritional Therapy Versus Guideline-Based Nutritional Advice for Sarcopenia in Decompensated Cirrhosis-A Randomised Controlled Trial.: Single-centre 6-month RCT (n=180) in decompensated cirrhosis with sarcopenia found dietitian-supervised intensive nutrition (35–40 kcal/kg/day, 1.2–1.5 g/kg/day protein) outperformed physician-led guideline advice on skeletal muscle index — a comparative-effectiveness nutrition-only test (no resistance-training arm) in a high-risk hepatology sarcopenia population alongside STRIVE’s planned RT + creatine/whey design. [human-rct] (novelty: 3)
- 2026-10-05 — Changes in physical performance and frailty-associated risk associated with participation in a community exercise programme: Findings from the ExWell cohort.: ExWell Ireland cohort (n=1290, 24 weeks) of a medically supported community exercise program with resistance components reported gains in sit-to-stand, TUG, and gait speed across frail, prefrail, and robust adults with chronic conditions — real-world uncontrolled extension of mixed-modality strength-inclusive programming into a national community-delivery context. [human-observational] (novelty: 3)
- 2026-10-01 — Physical Performance Moderates the Association Between Age and Executive Function in Older Adults at Elevated Risk of Dementia: Cross-Sectional Analysis From the CITA GO-ON Trial.: CITA GO-ON cross-sectional analysis in dementia-risk older adults found peak leg muscle power (alongside grip and gait) moderated the age–executive-function slope independent of body composition and cardiovascular factors — associational-only rationale support for strength/power preservation as a cognition-adjacent target, no intervention arm. [human-observational] (novelty: 3)
- 2026-10-01 — Dual-Tasking Exacerbates Force and Neural Control Unsteadiness in Older Adults With Sarcopenia.: Cross-sectional neuromuscular study showed sarcopenic older adults have substantially worse force steadiness and altered common synaptic input to motor units versus non-sarcopenic peers and masters athletes, with dual-task cognitive load widening the gap — extends the sarcopenia phenotype beyond mass/strength into neural-control fidelity, consistent with the motor cortex and cortical-drive branches of the mechanism map and reinforcing the case for training that targets neural as well as contractile properties. [human-observational] (novelty: 3)
- 2026-07-03 — Body composition’s effect on the bone-vascular axis of osteoporosis discovered in AI-based CT analysis of COPD patients.: AI-based CT study in COPD patients linked intermuscular adipose tissue (IMAT) independently to thoracic vascular calcification and flagged it as a marker of metabolic dysregulation, physical frailty, and arteriosclerosis beyond age or BMI — associational imaging work that reinforces the case-finding rationale for interventions targeting muscle fat infiltration (including resistance training) in multimorbid populations, no intervention arm. [human-observational] (novelty: 3)
- 2026-10-07 — Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP-1-Based Therapy.: Clinical-mechanistic review (no new data) distinguishes GLP-1-associated lean-mass loss from contractile muscle loss and reiterates protein intake, progressive resistance training, and functional monitoring as the muscle-preservation stack during incretin therapy — especially in older adults — adding another synthesis entry to the GLP-1 muscle-preservation discourse alongside Attia AMA #86, the ‘muscle percentage is not muscle preservation’ commentary, the Polish Society of Dietetics statement, and the incretin-therapy reframing review. [expert-opinion] (novelty: 3)
- 2026-10-02 — Diet and nutrition in obesity treated with incretin-based therapies: A scientific statement of the Polish Society of Dietetics.: Polish Society of Dietetics scientific statement (expert guidance, no new data) frames structured dietitian-led care — adequate protein, resistance exercise, Mediterranean/DASH or planned plant-based patterns, and targeted (not routine) supplementation — as essential during GLP-1 and dual GIP/GLP-1 obesity therapy to limit lean-mass loss and nutrient shortfalls, adding a society-level entry to the GLP-1 muscle-preservation stack alongside Attia AMA #86 and the incretin-therapy reframing commentaries. [expert-opinion] (novelty: 3)
- 2026-09-29 — Mitochondrial membrane lipid cardiolipin controls fiber-type adaptations in aging muscle via estrogen-related receptor γ.: Mouse genetics plus human muscle correlation study found aging-related decline in the mitochondrial membrane lipid cardiolipin causally drives skeletal-muscle fiber-type shifts via ERRγ retrograde signaling, and restoring Crls1 reestablished cardiolipin, reversed atrophy, and rescued premature mortality — adds a specific mitochondrial-lipid/ERRγ branch to the sarcopenia mechanism map upstream of fiber-type loss, no human intervention arm and does not displace resistance training as the human-evidenced lever. [animal-model] (novelty: 4)
- 2025-09-22 — Physical Functioning Improvements in Older Adults Following a Proprioceptive Neuromuscular Facilitation-Based Resisted Exercise Program: A Randomized Clinical Trial.: Small 4-week RCT (n=25) in older adults with limited physical function compared a PNF manual-resistance program against the same movements without resistance, reporting SPPB, gait speed, and sit-to-stand gains favoring the resisted arm — extends the resistance-training evidence to a manual/PNF modality in a brief, small-sample design. [human-rct] (novelty: 3)
- 2025-12-18 — Beyond strength: dietary nitrate augments self-selected functional mobility after resistance training in middle-aged adults.: 12-week pilot RCT in inactive middle-aged adults reported that daily nitrate-rich beetroot juice added to twice-weekly resistance training improved self-selected gait speed, stride length, and TUG beyond RT with placebo — adds dietary nitrate to the growing list of nutritional adjuncts (protein, creatine, HMB, blueberries, EVOO) tested on top of resistance training, at pilot scale and in a non-sarcopenia middle-aged population. [human-rct] (novelty: 3)
- 2026-07-15 — Chronic kidney disease-stratified plasma proteomic signatures of probable sarcopenia: A UK biobank cohort study.: UK Biobank proteomic study (n≈52k, 2920 proteins) delivered a CKD-stratified plasma signature of probable sarcopenia headed by COL6A3 (ECM remodeling) and GDF15 (inflammation/stress), with cis-pQTL and prospective support — adds a renal-stratified proteomic branch to the sarcopenia mechanism and case-finding map alongside the existing SMI/apelin/GDF15 biomarker panel, no intervention arm. [human-observational] (novelty: 3)
- 2026-08-05 — Nutritional Support With Or Without Exercise for Older Adults With GLIM-Compatible Malnutrition: A Meta-Analysis of Randomized Controlled Trials.: Meta-analysis of 17 RCTs in GLIM-malnourished older adults found adding exercise to nutritional support produced small-but-significant gains in lower-limb strength (moderate-certainty) over nutrition alone, with no clear benefit on muscle mass or lean body mass — extending the RT-plus-nutrition evidence stack into the GLIM-malnutrition subpopulation while reinforcing that mass endpoints lag functional ones. [human-rct] (novelty: 3)
- 2026-08-08 — Dynamic trajectories of possible sarcopenia under the AWGS 2025 criteria and long-term prognosis: A national landmark cohort study.: Chinese national landmark cohort (adults ≥60, ADL-intact at baseline) found persistent ‘possible sarcopenia’ defined by AWGS 2025 low-handgrip criteria independently associated with higher all-cause mortality and composite adverse outcomes, strengthening the AWGS 2025 case-finding frame that feeds resistance-training targeting — observational trajectory analysis, no intervention arm. [human-observational] (novelty: 3)
- 2026-08-13 — Effects of a multidomain intervention on physical performance and sarcopenia in long-term care facility residents: The I-COUNT pilot randomized controlled trial.: I-COUNT pilot cluster-RCT (6 months, LTCF residents ≥70) of a FINGER-style multidomain package (physical training + cognitive stimulation + Mediterranean diet with functional foods + vaccination promotion) improved SPPB and handgrip and showed a signal on slowed sarcopenia progression vs usual care — extends the multidomain-plus-nutrition testbed into institutionalized long-term care, pilot-scale and confirmatory rather than isolating the resistance-training contribution. [human-rct] (novelty: 3)
- 2026-08-10 — Dual-task versus single-task walking within an Otago Exercise Program for older adults with dementia: A 24-week cluster randomized controlled trial.: 24-week cluster RCT embedded dual-task walking in the Otago Exercise Program (strength-inclusive) in older adults with dementia; the dual-task layer added cognitive and gait-speed benefit over single-task Otago but the trial did not isolate a resistance-training contrast, so sarcopenia-relevant strength endpoints were not the mechanism tested. [human-rct] (novelty: 3)
- 2026-09-04 — Predicting Mobility and Functional Recovery After Hip Fracture With Handgrip Strength, Calf Circumference, and the SARC-F Questionnaire.: Prospective hip-fracture cohort (n=430, ≥70) found SARC-F outperformed handgrip strength and calf circumference for predicting post-fracture mobilization and functional recovery, extending the sarcopenia case-finding comparison between questionnaire-based and direct-measurement screens into an acute post-fracture population; associational, no intervention arm. [human-observational] (novelty: 3)
- 2026-09-29 — Infectious diseases and sarcopenia-related phenotypes: A phenome-wide Mendelian randomization study with exploratory proteomic analysis.: Phenome-wide two-sample MR screen linked genetic liability to tonsillitis and tuberculosis sequelae with lower appendicular lean mass and postzoster neuralgia with higher ALM, adding a genetic-instrument entry to the infection–sarcopenia branch of the mechanism map; exploratory, standard MR caveats, no intervention arm. [human-observational] (novelty: 3)
- 2026-10-01 — Metformin in Elderly Patients With Type 2 Diabetes and Muscle Strength, Muscle Mass, and Physical Function: Positive or Negative Correlation?: Propensity-matched observational study in elderly T2D patients linked long-term metformin use to worse grip strength and, under poor glycemic control, worse skeletal muscle mass and gait speed — adds a drug-exposure risk-stratification signal to the sarcopenia case-finding map alongside resistance training as the human-evidenced lever, with no intervention arm and standard confounding caveats. [human-observational] (novelty: 3)
- 2026-10-01 — A Mendelian randomization study reveals TNF-β as a potential protective factor against sarcopenia.: Two-sample MR screen of 91 inflammatory factors against sarcopenia traits (appendicular lean mass, grip strength, walking pace) singled out circulating TNF-β as causally protective, adding a cytokine-specific causal entry to the inflammaging–muscle-loss branch of the sarcopenia mechanism map; no intervention arm and standard MR caveats (pleiotropy, instrument strength) apply. [human-observational] (novelty: 3)
- 2026-10-01 — Effects of Daily Rhythm-Aligned Training on Skeletal Muscle Adaptation in Older Adults: A Randomized Controlled Trial.: Three-arm RCT in older adults randomizing resistance training to individual peak-performance vs trough diurnal window found no difference in isometric strength, handgrip, or lean mass — a clean null that constrains individualized time-of-day prescription as a lever on muscle adaptation. [human-rct] (novelty: 3)
- 2026-10-01 — Optimizing frailty care: an analysis of dual exercise targets and cognitive function among frail older adults.: Cross-sectional analysis (n=4477) in prefrail/frail older adults supports a dual-target (CRF + muscle strength) rather than strength-only prescription rationale for cognition in frailty, with strength contributing additively on top of CRF — associational only, no intervention arm. [human-observational] (novelty: 3)
- 2026-04-03 — EffectS of Lifestyle Interventions in Older PEople With Obesity (Effective SLOPE): a Systematic Review With Network Meta-Analyses.: Network meta-analysis of 72 RCTs (54 in NMA) in community-dwelling older adults with obesity (Effective SLOPE) found that combining nutrition + exercise + behavior-change interventions produced the best balance of physical-function gain and body/fat-mass reduction without clearly compromising fat-free mass or BMD — positions resistance-inclusive multimodal programs as the preferred backbone when weight loss is being pursued in older adults, with nutrition and behavior adjuncts additive rather than displacing training. [human-rct] (novelty: 3)
- 2026-06-09 — DXA-derived regional adiposity identifies hidden liver-metabolic risk beyond BMI in non-obese older adults: A cross-sectional study.: Cross-sectional DXA study in non-obese older adults linked low-muscle/high-VAT phenotypes to elevated fatty-liver indices and liver enzymes beyond BMI, reinforcing the case for identifying sarcopenia-adjacent body composition risk in people who look lean by BMI — associational, no intervention arm, and no direct resistance-training comparison. [human-observational] (novelty: 3)
- 2026-06-29 — Personalized blood flow restriction training at variable occlusion pressures improves multisystem function in overweight and obese older women.: 12-week RCT (overweight/obese older women) of low-intensity BFR training at 60–70% AOP produced dose-dependent muscular improvements, adding to the case that low-load BFR variants can serve as a resistance-training alternative in populations where high-load RT is less tolerable — extends BFR as an RT-adjacent lever for sarcopenia prevention in cardiometabolically compromised older women. [human-rct] (novelty: 3)
- 2026-08-20 — Effects of resistance training on balance-related physical performance in older adults with sarcopenic obesity: a systematic review and meta-analysis of randomized controlled trials.: Meta-analysis of 6 RCTs in older adults with sarcopenic obesity found standalone resistance training improved TUGT and SPPB and was well tolerated, though certainty was low to very low — extends the RT-for-sarcopenia case into the sarcopenic-obesity subpopulation specifically. [human-rct] (novelty: 3)
- 2026-09-30 — Sex- and age-specific patterns in bone, muscle, and fat across adulthood and their relation to osteosarcopenic adiposity phenotype: a cross-sectional study.: Large cross-sectional LOESS mapping (~9,700 adults) identified sex-specific inflection points for muscle and bone loss (earlier male peaks; sharper female midlife downturns around menopause) and found an osteosarcopenic adiposity phenotype marked by earlier, less stable musculoskeletal trajectories — sharpens the sex- and age-stratified targeting case for resistance training without any intervention data. [human-observational] [human-observational] (novelty: 3)
- 2026-10-01 — Consensus-Defined Sarcopenic Obesity and a Related Dynapenic Obesity Phenotype in Relation to Early Cognitive Impairment.: Prospective cohort finding that both consensus sarcopenic obesity and a dynapenic-obesity phenotype predict cognitive decline reinforces the rationale for strength-and-fat-mass–targeting interventions (RT + weight management), but is observational with no intervention arm. [human-observational] (novelty: 3)
- 2026-09-28 — Losing Muscle or Restoring Physiology? Reframing the Incretin Therapy Sarcopenia Concern.: Perspective review (no new data) reframes incretin-associated lean-mass loss as physiological body-composition remodeling comparable to other effective weight-loss interventions — preferential fat loss with improved physical function — rather than pathological sarcopenia, extending the GLP-1 muscle-preservation discourse already populated by Attia AMA #86 and the ‘muscle percentage is not muscle preservation’ commentary; does not displace resistance training as the human-evidenced lever. [expert-opinion] (novelty: 3)
- 2026-08-04 — Aging preserves mTORC1 but attenuates JNK-SMAD2L signaling sensitivity to passive stretch-induced tension development in isolated mouse skeletal muscle.: Ex vivo isolated mouse EDL study found passive stretch-induced tension preserves mTORC1 activation in aged muscle but attenuates JNK–SMAD2L mechanosensitivity, pointing to selective, pathway-specific anabolic resistance rather than global mechanotransduction failure — preclinical mechanism, no intervention or functional readout. [animal-model] (novelty: 3)
- 2026-09-14 — The Alpha-1 Antitrypsin Z-allele associates with sarcopenia in the UK Biobank: UK Biobank genetic association study reported the SERPINA1 Z allele (alpha-1 antitrypsin deficiency variant) was linked in a dose-dependent way to lower muscle mass and higher sarcopenia risk independent of lung and liver function, with modest mediation of increased mortality — expanding the AATD phenotype and adding a monogenic risk marker to the sarcopenia case-finding map, observational only. [human-observational] (novelty: 3)
- 2026-09-21 — VIVI-OLIVE: Multicomponent Exercise and Extra Virgin Olive Oil in Older Adults at High Risk of Falls: VIVI-OLIVE trial protocol (no readout) embeds the VIVIFRAIL multicomponent program (which includes resistance training) as the exercise backbone in a 24-month combination test with Mediterranean diet and EVOO in ≥75 high-fall-risk adults — another multicomponent-plus-nutrition test alongside STRONG and BIOANCIENT_EX. [expert-opinion] (novelty: 3)
- 2026-09-16 — RANKL Inhibition to Combat Sarcopenia in Hip Fracture Patients: Second registered pragmatic double-blind active-controlled RCT protocol (no readout) will test RANKL inhibition for sarcopenia — this time in hip fracture patients — adding another pharmacologic bone-pathway arm to the sarcopenia intervention landscape alongside resistance training as the human-evidenced lever. [expert-opinion] (novelty: 3)
- 2026-09-18 — RANK-ligand Inhibition to Combat Sarcopenia With Underlying Osteoporosis: Registered randomized double-blind double-dummy active-controlled trial (no readout) will test denosumab (RANK-ligand inhibition) for sarcopenia in older adults with underlying osteoporosis — a pharmacologic bone-drug repurposing entering the sarcopenia intervention landscape alongside, not replacing, resistance training as the human-evidenced lever. [expert-opinion] (novelty: 3)
- 2026-09-23 — Motor Cortex Hyperexcitability Is Coupled to Neuromuscular Dysfunction in Aged Mice: Aged-mouse Aging Cell study coupled motor cortex hyperexcitability to neuromuscular dysfunction, adding a cortical-drive branch upstream of muscle to the sarcopenia mechanism map — preclinical, no intervention arm and does not displace resistance training as the human-evidenced lever. [animal-model] (novelty: 3)
- 2026-09-17 — Muscle Percentage Is Not Muscle Preservation: Interpreting Body-Composition Outcomes During GLP-1 Weight Loss.: Interpretive review (no new data) argues that improved muscle percentage during GLP-1 weight loss does not equal muscle preservation, since percentage rises mechanically as fat mass drops; authors call for absolute lean-mass and functional endpoints when judging RT/protein adjunct trials in this population — a methodological correction on how the growing GLP-1 muscle-preservation stack should be evaluated, not a new outcome. [expert-opinion] (novelty: 3)
- 2026-09-25 — The Interplay of Metabolic Dysfunction, Neuroinflammation, and Mitochondrial Dysfunction in Balance Impairment: Insights from Type 2 Diabetes Mellitus and Alzheimer’s Disease.: Narrative review (no new data) positions neuromuscular decline in T2DM/AD as downstream of a metabolic–NLRP3–mitochondrial cycle affecting muscle and nerve, framing multimodal rehab (including resistance work) alongside GLP-1 agonists and mitochondrial antioxidants as candidate levers — mechanistic overlap with the sarcopenia case, no primary intervention data. [mechanism-plausible] (novelty: 3)
- 2026-09-24 — Impact of supervised physical exercise on inflammatory and oxidative stress biomarkers in older adults: a systematic review and meta-analysis of randomized controlled trials.: Meta-analysis of 50 supervised-exercise RCTs (n=4,379) in older adults — pooling resistance, aerobic, and mixed protocols — reported modest CRP reductions and IL-10 increases with inconsistent IL-6/TNF-α; modality-specific effects not disentangled, so resistance-training-specific contribution to inflammaging remains unresolved. [human-rct] (novelty: 3)
- 2026-06-06 — Association between bile acid metabolism and sarcopenia in older adults.: Matched case-control serum metabolomics in older adults associated elevated 3β-HDCA and GLCA with primary sarcopenia and reported a sleep-duration interaction (TLCA-linked risk markedly higher with >8 h sleep) — adds a human-association layer to the gut–bile-acid–muscle axis previously supported mainly by mouse work (BSH-Bifidobacterium/FXR-FGF15), without any intervention data. [human-observational] (novelty: 3)
- 2026-09-14 — A bi-directional Mendelian randomization study of sarcopenia-related traits and renal function.: Bidirectional two-sample MR on sarcopenia-related traits (appendicular lean mass, grip strength, walking pace) and renal function found reciprocal genetic associations — most consistent for urinary albumin excretion — adding a kidney branch to the sarcopenia causal-map alongside prior spine, brain-iron, and gut-microbiota entries; no intervention data, standard MR caveats apply. [human-observational] (novelty: 3)
- 2026-09-16 — Cross-organ crosstalk in brain-aging-related sarcopenia: Caudate iron accumulation impairs muscle health via blood-brain barrier dysfunction.: Genetic association analyses (MR/TWAS/SMR/mediation) tied caudate iron accumulation and blood–brain barrier dysfunction (pericyte CYBRD1, plasma TYRO3) to lower lean body mass and poorer muscle function, adding a brain-to-muscle etiologic branch to the sarcopenia mechanism map without any intervention or displacement of resistance training as the human-evidenced lever. [human-observational] (novelty: 3)
- 2026-09-16 — Associations of physical fitness with brain structure, pathology and cognition in cognitively normal older adults.: Cross-sectional study in cognitively normal older adults linked higher muscular fitness to lower basal-ganglia perivascular-space volume, adding a brain small-vessel-imaging correlate to the strength-preservation case — associational only, no intervention arm. [human-observational] (novelty: 3)
- 2026-09-18 — Evaluation of Beverage Can-opening Status as a Screening Indicator for Sarcopenia: A Cross-sectional Study.: Cross-sectional study in long-term-care older adults reported can-opening failure associated with AWGS sarcopenia (OR ~4.5, AUC 0.62), extending the pre-intervention case-finding front end with a zero-equipment behavioral cue — associational only, no intervention arm. [human-observational] (novelty: 3)
- 2026-09-20 — Persistent Postural-Perceptual Dizziness in Older Adults: Associations With Intrinsic Capacity Decline, Probable Sarcopenia and Geriatric Syndromes.: Cross-sectional clinic study reported persistent postural-perceptual dizziness in older adults was independently associated with probable sarcopenia (alongside frailty, depression, and falls), positioning a chronic vestibular condition as a candidate case-finding channel for sarcopenia — associational, no intervention arm. [human-observational] (novelty: 3)
- 2026-09-24 — Aging patterns based on the difference between physical fitness age and chronological age are associated with physical, mental, and cognitive health in older adults.: Same 2,207-adult Chinese cross-sectional study reported that a decelerated Physical Fitness Age (PFA younger than chronological age) was associated with remaining free of chronic disease, indirectly supporting the case for interventions that preserve strength and function — associational, no intervention arm, and the composite spans more than muscle. [human-observational] (novelty: 3)
- 2026-09-25 — Protective effects of sarcopenia-related traits on spinal degenerative diseases: A large prospective cohort study.: UK Biobank prospective cohort plus two-sample Mendelian randomization reported that higher appendicular and whole-body lean mass had protective causal effects against lumbar disc herniation and spinal stenosis, extending the sarcopenia-prevention case for resistance training from frailty and metabolic outcomes into spine-degeneration endpoints with a causal-inference lever (MR) rather than association alone. [human-observational] (novelty: 3)
- 2026-09-22 — Sarcopenic obesity is associated with more severe functional impairment and lumbar degeneration in patients with degenerative lumbar spinal stenosis.: Cross-sectional clinical study in degenerative lumbar spinal stenosis patients found sarcopenic obesity independently associated with worse functional impairment and more severe disc, foraminal, Modic, and paraspinal-muscle degeneration than sarcopenia alone, with fat mass amplifying sarcopenia’s adverse effects — extends the sarcopenic-obesity rationale for resistance-training + fat-mass targeting into a spine-degeneration clinical niche, observational only. [human-observational] (novelty: 3)
- 2026-09-23 — A probioticconverts hesperidin to bioactive hesperetin and improves metabolic dysfunction in aging mice.: Preclinical mouse study reported that probiotic strain CL256B, which bioconverts hesperidin to hesperetin, improved grip strength, body composition, and hepatic steatosis in aging Western-diet mice via CISD2/SIRT1 activation — adds another gut-microbiota branch (alongside the BSH-Bifidobacterium/FXR-FGF15 entry) to sarcopenia mechanism research without displacing resistance training as the human-evidenced lever. [animal-model] (novelty: 3)
- 2026-09-22 — Effects of anti-aging diets and exercise on age-related musculoskeletal diseases via gut microbiota modulation.: Narrative review positions exercise + anti-aging diets as jointly acting on sarcopenia (and osteoarthritis, bone loss) through gut-microbiota reshaping and reduced LPS-driven systemic inflammation, extending the gut–muscle axis rationale for resistance training but without new intervention data. [mechanism-plausible] (novelty: 3)
- 2026-09-22 — Effects of a self-selected vegetarian vs. omnivorous diet on protein intake and muscle mass in older adults during resistance exercise: the IMPACT randomized controlled trial.: IMPACT RCT in adults ≥55 doing 12 weeks of resistance training found a self-selected lacto-ovo vegetarian diet reached ≥1.2 g/kg/d protein and increased appendicular muscle mass and strength, but protein intake and muscle-mass gains were lower than with an omnivorous diet and non-inferiority was not established. [human-rct] (novelty: 3)
- 2026-09-19 — Strength training intervention with creatine/whey protein supplementation vs placebo on frailty in older adults with cirrhosis (STRIVE): A Randomized Controlled Trial.: STRIVE trial protocol (n=200, no readout) will test creatine + whey protein vs placebo added to a 12-week semi-supervised strength-training, nutrition, and life-skills program in adults ≥60 with Child–Pugh A–C cirrhosis, with Liver Frailty Index as the primary endpoint — extending the RT + creatine/whey adjunct stack into a high-need hepatology-frailty population. [expert-opinion] (novelty: 3)
- 2026-09-25 — Study on blueberries, protein and exercise for improving frailty and cardiovascular disease (STRONG): protocol for a parallel-group randomised controlled superiority trial in older Nova Scotians.: STRONG trial protocol (n=240, no readout) pairs thrice-weekly multimodal exercise with 30 g daily protein powder and blueberries vs usual care for one year in Nova Scotians 65+, with frailty as a primary endpoint — extends the RT-plus-protein-plus-nutraceutical frailty testbed into a year-long superiority design. [expert-opinion] (novelty: 3)
- 2026-09-17 — Validation and refinement of a biomarker panel for frailty assessment and prediction of muscle weakness in older adults.: Observational biomarker-panel study (SMI + apelin + GDF15) in a Japanese biobank cohort cross-validated the panel against J-CHS frailty components and forecast incident muscle weakness (C-index 0.70) in robust older adults — adds circulating apelin (already flagged in the sarcopenia sex-dimorphism review) and GDF15 to the sarcopenia risk-stratification toolkit that feeds resistance-training targeting, without intervention data. [human-observational] (novelty: 3)
- 2026-09-10 — Effects of a 12-week unsupervised and adapted physical activity prescription on physical per-formance in geriatric outpatients with overweight or obesity: the PACE tool: Single-arm 12-week home-based unsupervised PACE prescription in overweight/obese frail geriatric outpatients reported high adherence, improved lower-limb muscle function, and reduced probable-sarcopenia prevalence — pragmatic pre/post signal for a low-supervision delivery model without a control arm. [human-observational] (novelty: 3)
- 2026-09-11 — Preserved mitochondrial respiration in presence of oxidative stress and reduced mitochondrial mass after 10-day bed rest in older adults.: Controlled 10-day bed-rest study in healthy older men (small n) found skeletal-muscle mitochondrial ROS emission rose and mitochondrial mass fell while respiratory capacity was preserved, with OXPHOS transcripts down and mitophagy/antioxidant pathways altered — quantifies how fast disuse degrades the mitochondrial substrate that resistance training defends, placing redox imbalance upstream of respiratory failure. [human-rct] (novelty: 3)
- 2026-07-22 — Effect of Rg1-based Supplementation on Exercise Training-induced Stem Cell Recruitments and Skeletal Muscle Adaptation in Women Aged > 60: Registered trial protocol (no readout) will test Rg1-based Senactiv® supplementation as an adjunct to long-term exercise training in women >60, with bone-marrow stem-cell recruitment and skeletal-muscle adaptation as endpoints framed for sarcopenia and cognitive-decline prevention — extends the prior Rg1 + resistance-exercise crossover into a longer training-adjunct design with a branded commercial formulation. [expert-opinion] (novelty: 3)
- 2026-09-03 — Vivifrail Exercise Program in Nonagenarians: Effects on Function, Muscle, and Cognition: Vivifrail nonagenarian RCT protocol (no readout) will test home-based multicomponent training (strength included) at 2× vs 3× weekly on SPPB, muscle morphology, and cognition in community-dwelling ≥90-year-olds — a dose-comparison test of a resistance-inclusive frailty program at the extreme-age tail. [expert-opinion] (novelty: 3)
- 2026-06-17 — A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer: Longitudinal frailty-in-childhood-cancer-survivors study frames young adult survivors as a sarcopenia/frailty-vulnerable population identifiable decades before typical geriatric onset, motivating preventive exercise/resistance intervention targeting — observational risk-stratification work, no intervention readout. [human-observational] (novelty: 3)
- 2026-09-10 — Debunking the Frailty-sarcopenIa-ADT Axis in mEtastatic Prostate canceR With multiComponent Exercise: The FIERCE Trial: FIERCE trial protocol (no readout) will test a 16-week supervised clinic-based circuit of resistance and functional exercises plus self-directed aerobic exercise in pre-frail/frail metastatic prostate cancer patients on androgen deprivation therapy, with frailty, sarcopenia, and disease-progression endpoints — extending resistance-inclusive multicomponent programs into an iatrogenic-hypogonadal, advanced-cancer sarcopenia population. [expert-opinion] (novelty: 3)
- 2026-06-23 — Heat and Exercise in Aging as Therapy (HEAT): HEAT trial protocol (no readout) will read out muscle architecture and frailty indicators under local leg heat-pad therapy vs HIIT vs heat+HIIT in prediabetic older adults — a passive-heat adjunct arm entering the sarcopenia/frailty intervention landscape without a resistance-training comparator. [expert-opinion] (novelty: 3)
- 2026-08-28 — Effectiveness of a Multimodal Intervention on Function in Older Frail People With Diabetes in Latinamerican: Latin American multicentre pragmatic RCT protocol (target n=1050, frail/prefrail ≥65 with diabetes) embeds a 16-week structured exercise regimen alongside education and relaxed HbA1c/BP targets, with SPPB as a co-primary functional endpoint — protocol only, adds a large diabetes-frailty test of a resistance-inclusive multimodal package but no readout yet. [expert-opinion] (novelty: 3)
- 2026-07-21 — Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide: Registered trial protocol (no readout) will test a multi-disciplinary exercise-plus-nutrition intervention vs standard advice in adults ≥65 with T2D and obesity on weekly semaglutide, with muscle mass, strength, and physical function as sarcopenia endpoints — extending the GLP-1 muscle-preservation stack to a combined lifestyle arm alongside prior HMB+D and podcast-framing entries. [expert-opinion] (novelty: 3)
- 2026-06-11 — Creatine Supplementation and Resistance Training to Improve Sarcopenia Parameters in Patients With Prostate Cancer After Androgen Deprivation Therapy: Registered double-blind RCT protocol (no readout) will test creatine monohydrate plus 12-week supervised resistance training vs placebo+RT in men with prostate cancer on androgen deprivation therapy, with muscle mass, strength, density, and physical function as sarcopenia endpoints — extending the RT+adjunct sarcopenia stack into a specific iatrogenic-hypogonadal clinical niche. [expert-opinion] (novelty: 3)
- 2026-08-28 — HMB Plus Vitamin D to Preserve Muscle in Older Adults Starting Semaglutide: Registered double-blind RCT protocol (no readout) will test daily calcium-HMB + vitamin D3 vs placebo for 6 months in adults 65–85 with T2D newly starting semaglutide, with appendicular lean mass, physical function, and resting metabolism as endpoints — first dedicated test of the HMB+D nutraceutical arm of the GLP-1 muscle-preservation stack in older adults. [expert-opinion] (novelty: 4)
- 2026-08-24 — Effects of Blood Flow Restriction Training on Muscle Strength and Physical Function for Stroke-Related Sarcopenia: Sham-controlled RCT protocol (no readout) testing BFR walking vs sham-BFR walking in chronic stroke patients with sarcopenia on strength, physical function, muscle mass, vascular function, and quality of life — planned trial extending low-load BFR modalities as a resistance-training alternative in a high-need clinical sarcopenia group. [expert-opinion] (novelty: 3)
- 2026-08-10 — Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX): M3AX study protocol (design description, no results): combined public-health-guideline endurance + resistance training in older adults paired with multidimensional predictive modeling to dissect why some participants gain little strength/function from a standard resistance-inclusive dose — targets the responder-heterogeneity problem that meta-analyses of RT+protein/HMB routinely flag. [expert-opinion] (novelty: 3)
- 2026-06-17 — Multicomponent Program on a Group of Nonagenarians: 8-month twice-weekly multicomponent (strength-inclusive) exercise trial in nonagenarians measured upper/lower-limb strength, body composition, and BMD, comparing institutionalized vs community-dwelling participants — a rare long-duration test of resistance-inclusive training at the extreme-age tail where sarcopenia is near-universal. [human-rct] (novelty: 3)
- 2026-07-29 — Aging Resilience Through Microbiota Optimization and Regulation: Planned trial description (no data) proposing lyophilized fecal microbiota capsules from young, physically active donors as an intervention to improve muscle, cognitive, and metabolic function in older adults — a gut–muscle axis adjunct being positioned alongside (not replacing) resistance training for sarcopenia. [expert-opinion] (novelty: 3)
- 2026-09-01 — BIOANCIENT_EX: Effects of a Physical Exercise Program in Centenarians of the BIOANCIENT Cohort: A Randomized Clinical Trial.: BIOANCIENT_EX trial protocol (no readout yet): planned RCT of a home multicomponent program that includes a strength component in centenarians, aiming at functional capacity and biological markers — a rare test of resistance-inclusive training at the far end of the lifespan where sarcopenia is near-universal. [expert-opinion] (novelty: 3)
- 2026-07-08 — Effects of Cyclical Blood Flow Restriction Exercise on Muscle Hypertrophy and Capillaries in Older Adults: 8-week three-arm trial of low-load upper-body resistance exercise ± cyclical BFR cuffs vs no-exercise control in older adults probed arm muscle thickness and nailfold capillaries — small early-phase evidence that a low-load BFR variant may reach hypertrophy and microvascular endpoints relevant to sarcopenia. [human-rct] (novelty: 3)
- 2026-06-29 — #398 ‒ AMA #86: GLP-1 RAs and muscle loss: new data, better questions, and how to preserve muscle during weight loss: Attia AMA #86 (podcast, no new data) argues that when GLP-1 RA patients are counseled on adequate protein intake and structured resistance training, lean-mass loss during weight loss is minimal — a clinical-framing echo of the recent incretin+muscle review, positioning resistance training and protein as the standard mitigation stack. [expert-opinion] (novelty: 3)
- 2026-04-13 — The metabolic-inflammatory axis in aging: A multi-organ framework anchored in Sarcopenia - A review.: Narrative review proposes a multi-organ ‘GLAM’ (gut–liver–adipose–muscle) framework in which sarcopenia anchors a metabolic-inflammatory axis driven by insulin resistance and shared AMPK/mTOR, mtROS–p53, and AcCoA–HAT nutrient-sensing/epigenetic modules — a conceptual synthesis extending the sarcopenia case to systemic aging, no new primary data. [mechanism-plausible] (novelty: 3)
- 2026-06-19 — Amino acid and appendicular skeletal muscle mass insufficiency are associated to cognitive decline in Chinese population.: Cross-sectional Chinese multi-center metabolomics study (~1,500) plus independent community cohort (~6,000) found that low serum essential amino acids together with reduced appendicular skeletal muscle mass were associated with poorer cognitive capability, proposing a peripheral muscle–amino acid metabolic signature linking sarcopenia to cognitive decline (cross-sectional, non-interventional). [human-observational] (novelty: 3)
- 2026-04-30 — Damage-induced muscle regeneration after exercise in humans: Modulatory effects of ginsenoside Rg1.: Narrative review synthesizes prior human muscle-biopsy and exercise-adaptation data on ginsenoside Rg1 into a damage–regeneration framework, proposing Rg1 as the only ginsenoside with human biopsy support for modulating exercise-induced muscle injury, reducing perceived exertion, and exerting senolytic effects post-injury — mechanistic synthesis extending the earlier Rg1 + resistance-exercise RCT, no new primary readout. [mechanism-plausible] (novelty: 3)
- 2026-06-26 — Hormonal dimorphism in sarcopenia disease.: Narrative review argues sarcopenia progresses via sex-dimorphic hormonal pathways — apelin, insulin, and oxytocin differing between men and women — and calls for sex-stratified exercise/nutrition/pharmacologic care rather than unisex protocols; mechanistic framing only, no new primary data. [mechanism-plausible] (novelty: 3)
- 2026-06-29 — Study protocol for FAXAge: a randomized, controlled clinical trial of fasting and exercise to slow aging in humans.: FAXAge trial protocol (design paper, no results): 240 adults ≥65 randomized to 52 weeks of combined cardio+strength exercise, time-restricted feeding, both, or control, with DunedinPACE as primary readout and multi-omic phenotyping — a planned test of whether resistance-inclusive training (alone or with TRF) slows a pace-of-aging clock in older adults. [expert-opinion] (novelty: 4)
- 2026-04-02 — Ginsenoside Rg1 enhances stem cell abundance in aging human skeletal muscle after resistance exercise.: Small randomized crossover trial in women >60 reported that 10 mg ginsenoside Rg1 taken before a resistance-exercise bout roughly doubled high-mitochondrial mesenchymal stem cells and total mitochondrial content in muscle, attenuated progenitor depletion, and blunted exercise-induced drops in estradiol/progesterone versus exercise alone — early human signal that a TCM adjunct may amplify the stem-cell/mitochondrial response to strength training in older women, not a functional or mass endpoint. [human-rct] (novelty: 3)
- 2026-07-03 — Delayed molecular aging, preservation of energy metabolism and enhanced exercise response in exercise-trained human muscle.: Human multiomic muscle atlas of trained vs untrained older adults found trained muscle retained roughly half of a youth-like energy-metabolism transcriptomic/lipidomic/metabolomic signature and mounted larger acute exercise responses, adding molecular preservation evidence to the sarcopenia-prevention case for sustained training (observational, mixed training modalities). [human-observational] (novelty: 3)
- 2026-07-13 — Sleep-related Alzheimer’s disease vulnerability in aging: A muscle-metabolic perspective.: Narrative review proposes a sleep–muscle–brain axis in which sarcopenia, sarcopenic obesity, and insulin resistance destabilize sleep and lower the threshold at which sleep disruption drives Alzheimer’s amyloid/tau dyshomeostasis and impaired glymphatic clearance, with irisin/FNDC5–BDNF flagged as a hypothesis-generating link — conceptual synthesis extending resistance-training rationale to brain aging, no new primary data. [mechanism-plausible] (novelty: 3)
- 2026-07-19 — Rethinking frailty as a disorder of mitochondrial adaptability, from energetic congestion to systemic vulnerability.: Perspective review reframes frailty as ‘energetic congestion’ — a mismatch between substrate delivery and declining energetic demand that impairs mitochondrial adaptability — and predicts demand-driven interventions like structured resistance/exercise training will outperform energy-supplementation strategies for frailty/sarcopenia; conceptual model, no new primary data. [mechanism-plausible] (novelty: 3)
- 2026-07-01 — Combined Time-Restricted Feeding and Physical Exercise Attenuate ER Stress and Improve Liver Inflammation and Collagen Deposition in Aged Mice.: Aged-mouse study using mixed aerobic + resistance exercise alongside time-restricted feeding found the combined arm outperformed TRF alone on hepatic ER stress, inflammation, and collagen deposition — a preclinical off-target (liver) signal for resistance-inclusive training protocols, not a muscle or sarcopenia endpoint. [animal-model] (novelty: 3)
- 2026-07-09 — Enhancing sarcopenia screening in primary care: a machine learning approach using simple physical tests vs. SARC-F in 2,788 community-dwelling older adults.: Cross-sectional screening study (n=2,788) using an XGBoost model of brief physical tests detected sarcopenia at AUC 0.92 vs. SARC-F’s much lower sensitivity, with 5-times sit-to-stand (an exploratory ≥12-s threshold) the strongest single predictor — sharpening the case-finding front end that feeds resistance-training intervention pathways, though the study is diagnostic and internally validated only. [human-observational] (novelty: 3)
- 2026-07-04 — Reduced Synaptophysin-like 2 (MG29/SYPL2) Levels Mimic Age-Related Alterations in Skeletal Muscle Calcium Homeostasis and Lipid Signaling.: Preclinical mouse/myotube study reported that reduced MG29/SYPL2 levels disrupt triad membrane cholesterol, store-operated calcium entry, and lipid mediator signaling, recapitulating age-related sarcopenia phenotypes and adding a specific molecular organizer of excitation-contraction coupling loss to the sarcopenia mechanism map. [animal-model] (novelty: 3)
- 2026-07-28 — Bile salt hydrolase-active bifidobacterium animalis improves sarcopenia via the gut microbiota-bile acid-FXR-FGF15 axis and its functional fermented milk preparation.: Preclinical mouse study reported BSH-active Bifidobacterium animalis strains (deliverable via fermented milk) reversed dexamethasone-induced sarcopenia by remodeling bile acids and activating an intestinal FXR–FGF15/FGFR4 axis, adding a gut-microbiota mechanistic branch to sarcopenia intervention research but not displacing resistance training as the human-evidenced lever. [animal-model] (novelty: 3)
- 2026-08-03 — Epigenetic aging during adjuvant chemotherapy for colon cancer and modification by a resistance training intervention.: RCT in adjuvant colon-cancer chemotherapy patients found resistance training attenuated GrimAge epigenetic-age acceleration versus usual care, extending the strength-training case beyond function/mass to a molecular aging readout in a treatment-stressed population (single-cancer setting, clock-specific effect). [human-rct] (novelty: 3)
- 2026-08-03 — Physical Fitness and All-Cause Mortality in Older Adults.: Taiwanese cohort of ~13k older adults (~7-yr follow-up) identified lower-body strength as one of the dominant fitness domains predicting all-cause mortality, reinforcing the observational case for preserving muscular strength in aging (associational, not interventional). [human-observational] (novelty: 3)
- 2026-08-10 — Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization.: Geroscience-framed narrative review of knee osteoarthritis positions weight reduction, exercise, and education as the core disease-modifying levers for joint aging, while ranking pharmacologic/injectable options as mainly symptomatic and flagging genicular artery embolization as not yet validated against sham — reinforcing exercise as the load-bearing intervention for a major driver of late-life functional loss. [expert-opinion] (novelty: 3)
- 2026-08-04 — Effect of dance intervention on cardiorespiratory fitness and quality of life of older adults: a systematic review and meta-analysis.: Same 17-RCT meta-analysis (n=1,881) reported dance interventions outperformed conventional exercise on muscle strength outcomes in older adults, suggesting dance may carry a strength-training signal beyond its aerobic component. [human-rct] (novelty: 3)
- 2026-08-02 — Rhythmic Metabolism in Osteosarcopenia: Emerging Evidence, a Chronometabolomic Framework for the Bone-Muscle Unit, and Research Priorities.: Narrative review proposing ‘chronometabolomics’ as a framework for the bone–muscle unit in osteosarcopenia lists light, sleep regularity, protein distribution, time-restricted eating, and exercise/medication timing as trial-worthy levers, while explicitly noting direct human evidence linking disrupted metabolic rhythms to bone–muscle decline is scarce. [expert-opinion] (novelty: 3)
- 2026-08-17 — Epigenetic Skeletal Muscle Memory: The Impact of Physical Activity on Aging and Post-Injury Regeneration.: Review synthesizing epigenetic and cellular ‘muscle memory’ argues prior loading leaves structural and epigenetic traces that speed retraining and regeneration, while aging-driven epigenetic drift, chronic inflammation, and satellite-cell dysfunction erode this plasticity — positioning sustained resistance exercise as the best-established preservation lever. [mechanism-plausible] (novelty: 3)
- 2026-08-14 — Beyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity.: 2026-09-01 — Narrative review on skeletal muscle during semaglutide/tirzepatide therapy in diabesity notes lean mass loss roughly proportional to total weight loss (tirzepatide may reduce muscle fat infiltration), and positions resistance training plus adequate protein and functional assessment as muscle-preservation levers during incretin therapy, especially in older adults. [expert-opinion] (novelty: 3) [expert-opinion] (novelty: 3)
- 2026-09-01 — Combined effects of strength training, whey protein, and HMB on sarcopenia in older people: A systematic review and meta-analysis.: Systematic review and meta-analysis of 7 RCTs in older adults with sarcopenia found that resistance training combined with whey protein or HMB may improve fat-free mass and selected physical performance outcomes, though authors flag small pooled N and bias concerns and stop short of a definitive effect. [human-rct] (novelty: 3)
Open questions
Related
Contributing findings
Strength or cardio: What’s more important for longevity?
15-nov-2026
novelty 2
per-area 2
mentions
Circulating C-Terminal Agrin Fragment is Associated with Impaired Physical Performance in Aging and Chronic Disease: A Systematic Review and Meta-Analysis.
15-nov-2026
novelty 3
per-area 3
strengthens
Efficacy of Virtual Reality Exercises in Sarcopenic Patients After Liver Transplantation: A Randomized Controlled Clinical Study.
14-nov-2026
novelty 3
per-area 3
strengthens
Satellite cell attrition and skeletal muscle aging.
13-nov-2026
novelty 2
per-area 2
mentions
Results of Progressive Resistance Training in Older Type 2 Diabetic Patients With Sarcopenia
12-nov-2026
novelty 2
per-area 2
strengthens
Skeletal Muscle Aging and Responsiveness in Aged People With MS
12-nov-2026
novelty 2
per-area 2
mentions
Reframing the gut-muscle axis through the lens of functional redundancy: A conceptual framework for chronic sarcopenia, acute muscle wasting, and microbiota-related interventions.
12-nov-2026
novelty 2
per-area 2
mentions
Failure of Protein Quality Control Mechanisms in Muscle Aging
11-nov-2026
novelty 2
per-area 2
mentions
Depressive symptoms, possible sarcopenia, and functional disability among Chinese adults aged 50 years or more: A five-wave longitudinal study.
10-nov-2026
novelty 2
per-area 2
strengthens
Twelve-week changes in physical function among older hemodialysis patients receiving intradialytic electrical muscle stimulation or resistance training: a multicenter exploratory comparative observational study.
10-nov-2026
novelty 2
per-area 2
strengthens
Body recomposition in adults: mechanisms, modulators, and practical algorithms for simultaneous skeletal muscle mass gain and fat mass loss.
10-nov-2026
novelty 2
per-area 2
strengthens
PROfiles of FGF-19 Post-prandial Secretion in Older Adults With Frailty and Without Frailty
10-nov-2026
novelty 3
per-area 2
mentions
Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes
09-nov-2026
novelty 3
per-area 3
strengthens
CLUSTER TRAINING + CREATINE PROJECT
09-nov-2026
novelty 2
per-area 2
strengthens
Assessments of Sarcopenia Prevalence in Chronic Heart Failure Patients and in Subjects Before TAVI
09-nov-2026
novelty 2
per-area 2
mentions
Effectiveness of a Physical Exercise Prescription Program in Primary Care for Adults Aged 65 and Older: PREFIS-AP
09-nov-2026
novelty 3
per-area 3
strengthens
Factors associated with skeletal muscle mass in patients with Behçet's disease: An exploratory study.
07-nov-2026
novelty 2
per-area 2
strengthens
Evidence for spermine oxidase (SMOX) as a regulator of skeletal muscle mass throughout the lifespan.
03-nov-2026
novelty 3
per-area 3
strengthens
Prevalence and associated factors of sarcopenia among community-dwelling older adults in Vietnam: A cross-sectional study.
01-nov-2026
novelty 2
per-area 2
strengthens
Women With Bipolar Disorder are at Increased Risk of Sarcopenia.
01-nov-2026
novelty 3
per-area 3
strengthens
Effects of a Nurse-Led Multicomponent Exercise Intervention for Haemodialysis Patients With Possible or Confirmed Sarcopenia: A Cluster Randomised Trial.
01-nov-2026
novelty 2
per-area 2
strengthens
Discordance Between Height- and BMI-Adjusted AWGS 2025 Definitions of Confirmed Sarcopenia After Stroke.
01-nov-2026
novelty 3
per-area 3
strengthens
Exercise and Nutritional Interventions for Muscle Strength, Physical Performance, and Body Composition Among Older Adults With Sarcopenia or Pre-Sarcopenia: A Network Meta-Analysis.
01-nov-2026
novelty 3
per-area 3
strengthens
Adult-onset Still's disease and sarcopenia-related traits - muscle mass, strength, and function: A bi-directional Mendelian randomization study.
01-nov-2026
novelty 2
per-area 2
strengthens
The effects of regular exercise and psychoeducation on quality of life, depression, and physical function in older adults with sarcopenia: A single-blind randomized controlled trial.
31-oct-2026
novelty 3
per-area 3
strengthens
Obesity Medications in Older Adults: A Geriatrics 5Ms Framework for Safe and Patient-Centered Prescribing.
29-oct-2026
novelty 3
per-area 3
strengthens
Acute and Chronic Cardiovascular and Neuromuscular Effects of Blood Flow Restriction Resistance Training in Older Adults: A Systematic Review and Meta-Analysis.
28-oct-2026
novelty 3
per-area 3
strengthens
Corrigendum to "Effect of aerobic or resistance exercise, or both on insulin secretion, ciliary neurotrophic factor, and insulin-like growth factor-1 in dieting older adults with obesity" [Clin Nutr 51 (2025) 50-62].
28-oct-2026
novelty 1
per-area 1
mentions
Prevalence and factors associated with sarcopenia in individuals with stroke undergoing rehabilitation: A cross-sectional study.
26-oct-2026
novelty 2
per-area 2
strengthens
Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine.
26-oct-2026
novelty 3
per-area 3
strengthens
Optimal Vitamin C Status is Associated with Better Physical Performance in Men and Women from the EPIC-Norfolk Cohort: A Cross-Sectional Study.
24-oct-2026
novelty 2
per-area 2
strengthens
Individual variability and predictors of responsiveness in physical outcomes following multicomponent physical training in older adults.
24-oct-2026
novelty 3
per-area 3
strengthens
Human serum collected after fermented whey protein supplementation stimulates myocellular growth and protein synthesis: A randomized, double-blind, active-controlled crossover trial.
23-oct-2026
novelty 3
per-area 2
mentions
Effects of resistance training on frailty-related outcomes in frail and pre-frail older adults: a systematic review and meta-analysis of randomized controlled trials.
22-oct-2026
novelty 2
per-area 2
strengthens
Resistance Training Improves Respiratory Muscle Strength and Immune Response in Older Adults: A Randomized Clinical Trial.
19-oct-2026
novelty 3
per-area 3
strengthens
Blood Flow Restriction Training in Seniors: An Alternative to High-Load Resistance Training.
17-oct-2026
novelty 2
per-area 2
strengthens
Glucose-Lowering Therapies in Type 2 Diabetes-Associated Sarcopenia: Mechanisms, Clinical Evidence and a Muscle-Centred Framework.
17-oct-2026
novelty 3
per-area 3
strengthens
Common questions and misconceptions about diets: what does the scientific evidence really show?
15-oct-2026
novelty 2
per-area 2
mentions
Effects of exercise snacks combining resistance training and Wuqinxi on older adults with possible sarcopenia in nursing homes: protocol for a randomized controlled trial.
14-oct-2026
novelty 2
per-area 2
mentions
Navigating machine learning and classical statistics in sarcopenia screening for community-dwelling older women.
12-oct-2026
novelty 2
per-area 2
strengthens
Prevalence and impact of sarcopenic obesity at hospital admission according to ESPEN-EASO approach on functional status of older adults: results of a retrospective and prospective observational study.
10-oct-2026
novelty 2
per-area 2
strengthens
Effects of exercise interventions based on American College of Sports Medicine recommendations on physical function, body composition, and quality of life in older adults with sarcopenia: a meta-analysis of randomized controlled trials.
09-oct-2026
novelty 2
per-area 2
strengthens
Characteristics of Older Adults with Favorable Locomotive Syndrome and Frailty Outcomes Following Locomotion Training: A Preliminary Pre-Post Study.
08-oct-2026
novelty 2
per-area 2
strengthens
Is There a Relationship Between the Gut Microbiome and the Functional Capabilities of Skeletal Muscle? A Narrative Review.
08-oct-2026
novelty 2
per-area 3
strengthens
Lysine degradation-related metabolic remodeling in sarcopenia: Mendelian randomization prioritization and multi-omics-based characterization.
07-oct-2026
novelty 3
per-area 3
strengthens
Optimizing health outcomes for older adults with sarcopenic obesity: a scoping review of nutrition, exercise and combined interventions.
07-oct-2026
novelty 2
per-area 2
strengthens
Weight Loss or Muscle Loss? Cellular Mechanisms and Clinical Strategies for Preserving Lean Mass During GLP-1-Based Therapy.
07-oct-2026
novelty 3
per-area 3
strengthens
The Effect of Adding Elastic Resistance Training in Routine Physical Exercise on Walking Speed of Elderly People With Sarcopenia in Griya Wreda Jambangan, Surabaya
06-oct-2026
novelty 2
per-area 2
strengthens
Women in Action: A Multicomponent Intervention for Older Women
06-oct-2026
novelty 2
per-area 2
mentions
Reduced Cardiolipin Levels as a Cause of Mitochondrial Dysfunction and Muscle Remodeling
06-oct-2026
novelty 2
per-area 2
strengthens